IRX3 and acute myeloid leukemia: High IRX3 expression in AML was strongly and positively associated with the presence of an NPM1 mutation or a FLT3 internal tandem duplication (Tables S3 and S4) (Wouters et al., 2009, Ley et al., 2013).